Nashik, May 08: On World Thalassemia Day, Samyak Ghoderao, a 10-year-old survivor of Thalassemia Major from Nashik, reunited with Dr Priyatesh Dwivedi, marking a heart-rending moment in his journey of triumph against the disease. Samyak's story is one of resilience and medical breakthroughs, underscored by a successful Haploidentical (half-match) Stem Cell Transplant performed at HCG Manavata Cancer Centre (HCGMCC). Diagnosed with Thalassemia Major at the tender age of six months, Samyak's life depended on regular blood transfusions. The absence of a full match donor posed a significant challenge until his family sought help from Dr Dwivedi, renowned for his expertise in Hematology and Stem Cell Transplants.

In November 2022, Dr Dwivedi, with his pioneering approach, opted for the complex yet life-changing Haploidentical Stem Cell Transplant, where Samyak's father served as the donor. This decision defied the odds associated with the procedure and marked a historic milestone as the first successful half-match Thalassemia Major Transplant in North Maharashtra.

Observed on May 8th annually, World Thalassemia Day holds significance in raising awareness about Thalassemia, a genetic blood disorder that affects millions worldwide. The day serves as a platform to educate communities, promote early detection and highlight the importance of comprehensive treatment approaches.

Today, Samyak leads a healthy life, free from the burden of regular blood transfusions. His visit to HCGMCC on World Thalassemia Day was a heartfelt expression of gratitude towards Dr Dwivedi, whose expertise and compassion turned the tide in his battle against Thalassemia Major.

About HCG Manavata Cancer Centre (HCGMCC): -

Established in 2007 by Dr Raj Nagarkar, HCGMCC – Nashik is Central India's first NABH-accredited facility. With over 50 consultant oncologists, 900 staff members and a 300-bed capacity, HCGMCC is a leading institution, offering holistic cancer treatment. Specializing in surgical, radiation and medical oncology, the centre has conducted 65,000 surgeries, including 1,000 robotic-assisted procedures. Patient-centric and multidisciplinary, HCGMCC recommends treatments to individual needs. Beyond clinical excellence, the centre’s financial aid programs underscore its commitment to accessibility and community well-being, redefining cancer care in the pursuit of a cancer-free future.